Description
Book SynopsisThis book provides an in-depth view on engineered nanomaterials (ENM) pulmonary effects and familiarizes readers with unique aspects of nanomaterial application and research, such as the effects of physicochemical properties on cellular uptake and toxicity. It focuses on the diagnostic and therapeutic utilities of nanomaterials in different lung diseases. The book discusses the novel applications of nanotechnology for the treatment of airway diseases such as asthma, allergy, chronic obstructive pulmonary diseases, cystic fibrosis, and lung cancer. It also discusses the strategies to overcome the pathophysiological and technical barriers as an attempt to synchronize the efforts of pulmonary biologists, chemists and clinicians to develop novel nano-based diagnostics, imaging, and therapeutics tools for airway diseases.
Trade Review"Pulmonary Nanomedicine presents comprehensive information on emerging nanotechnology applications in diagnosing and treating pulmonary diseases. It describes numerous drug delivery, gene delivery, and theragnostic approaches for managing pulmonary disease outcomes. The book’s editor, Dr. Neeraj Vij, is an expert in pulmonary medicine and has done an excellent job in producing a high-class textbook."
—Prof. Rajiv R. Mohan - University of Missouri—Columbia, USA
"This book is a comprehensive treatise on emerging nanotechnology applications in the diagnosis and treatment of pulmonary diseases. It beautifully presents new drug delivery, gene delivery, and theragnostic approaches to improve pulmonary disease outcomes."
—Prof. Uday B. Kompella - University of Colorado, USA
Table of ContentsTheranostic Applications of Nanotechnology in Chronic Obstructive Lung Diseases. Multifunctional Tumor Targeted Nanoparticles for Lung Cancer. Nasal and Pulmonary Delivery of Macromolecules to Treat Respiratory and Non-Respiratory Diseases. In vitro and in vivo Diagnosis of Pulmonary Disorders using Nanotechnology. Nanoparticles for Targeting T Cells in Allergy and Inflammatory Airway Conditions. Multifunctional Chitosan Nanoparticles for Asthma. Targeted Felivery to Pulmonary Endothelium. Nano-Systems for Selective Epithelial Barrier Targeting in Chronic Airway Diseases. Health Risks of Engineered Nanomaterials in Pre-Existing Lung Disease.
